AATS/ACCF Heart Valve Summit: Medical, Surgical and Interventional Decision Making

Valvular heart disease affects more than 5 million individuals in the United States alone, can be congenital or acquired and may or may not be symptomatic for patients. While national guidelines inform the care, controversies in care within advancing technological and medical arenas demand collaborative methods of diagnosis and strategies for medical, surgical and interventional management.